For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bioline Rx Ltd ADR (NASDAQ: BLRX) closed the day trading at $0.76 down -10.05% from the previous closing price of $0.85. In other words, the price has decreased by -$10.05 from its previous closing price. On the day, 0.67 million shares were traded. BLRX stock price reached its highest trading level at $0.85 during the session, while it also had its lowest trading level at $0.7542.
Ratios:
For a better understanding of BLRX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.05 and its Current Ratio is at 1.14. In the meantime, Its Debt-to-Equity ratio is 0.87 whereas as Long-Term Debt/Eq ratio is at 0.55.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Maxim Group on May 18, 2017, Upgraded its rating to Buy and sets its target price to $3 from $1 previously.
On February 13, 2017, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $3.
Maxim Group Downgraded its Buy to Hold on August 12, 2016, whereas the target price for the stock was revised from $4 to $1.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BLRX now has a Market Capitalization of 63907176 and an Enterprise Value of 813947072. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.25 while its Price-to-Book (P/B) ratio in mrq is 4.24. Its current Enterprise Value per Revenue stands at 69.837 whereas that against EBITDA is -21.705.
Stock Price History:
Over the past 52 weeks, BLRX has reached a high of $2.53, while it has fallen to a 52-week low of $0.51. The 50-Day Moving Average of the stock is 13.30%, while the 200-Day Moving Average is calculated to be -30.59%.
Shares Statistics:
Over the past 3-months, BLRX traded about 335.44K shares per day on average, while over the past 10 days, BLRX traded about 447080 shares per day. A total of 79.94M shares are outstanding, with a floating share count of 79.50M. Insiders hold about 0.56% of the company’s shares, while institutions hold 1.76% stake in the company. Shares short for BLRX as of 1721001600 were 119732 with a Short Ratio of 0.36, compared to 1718323200 on 212051.
